4//SEC Filing
Mowry Anna 4
Accession 0001808805-25-000051
CIK 0001808805other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:12 PM ET
Size
5.5 KB
Accession
0001808805-25-000051
Insider Transaction Report
Form 4
Mowry Anna
CFO and Treasurer
Transactions
- Purchase
Common Stock
2025-05-29$0.77/sh+15,000$11,489→ 83,000 total
Footnotes (2)
- [F1]Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $0.7662 to $0.7489 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes the following shares of Common Stock acquired through the Issuer's 2021 Employee Stock Purchase Plan: (i) 1,250 shares on December 1, 2022; (ii) 1,250 shares on June 1, 2023; (iii) 1,250 shares on December 1, 2023; (iv) 2,500 shares on May 31, 2024; (v) 2,500 shares on November 29, 2024; and (vi) 2,500 shares on May 30, 2025.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001856938
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:12 PM ET
- Size
- 5.5 KB